Home > Healthcare > Medical Devices > Medical Supplies > us ophthalmic sutures market
Get a free sample of U.S. Ophthalmic Sutures Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of U.S. Ophthalmic Sutures Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
U.S. Ophthalmic Sutures Market Size was valued at more than USD 296 million in 2022 and is expected to observe a 5.5% CAGR through 2032. Growing prevalence of eye diseases in the U.S. is anticipated to expedite the market growth in the coming years.
Disorders such as cataract, glaucoma, and detached retina have added to the eye disease burden in the region. As per the National Eye Institute, around 24 million Americans are presently suffering from cataract and an estimated 38.7 million will be affected by the disease by 2030. Usually, surgeries are recommended to treat such severe eye diseases to improve vision. Hence, these diseases are contributing to the demand for ophthalmic suture products that provide optimum outcomes in related surgical procedures.
Demand for natural ophthalmic sutures in the U.S. is expected to reach around USD 163 million through 2032, thanks to the adequate strength, self-degradation absorption, and non-irritating carcinogenic characteristics of the product.
U.S. market for ophthalmic sutures was valued at over USD 296 million in 2022 and is projected to observe a 5.5% CAGR through 2032, owing to the growing prevalence of eye diseases in the region.
Some prominent companies operating in the regional market include Medtronic, Mani, Corzamedical, Teleflex Incorporated, Ethicon, B Braun Melsungen AG, and DemeTECH Corporation among others.
U.S. ophthalmic sutures industry share from the hospital segment is projected to reach USD 297 million through 2032, with better healthcare infrastructure and professional aid offered by these institutions.